a ∣ NKILA inactivates the nuclear factor-κB (NF-κB) pathway in breast cancer cells, and NKILA downregulation leads to decreased metastatic potential. In tumour-infiltrating T lymphocytes, NKILA leads to sensitization to activation-induced ceLL death. b ∣ CamK-A activates NF-κB in response to microenvironmental hypoxia, leading to activation of IL-6/IL-8 and VEGF, which increase macrophage recruitment and angiogenesis. c ∣ LNMAT1 activates CCL2 and CCL2-dependent macrophage recruitment in bladder cancer metastasis. hnRNPL, heterogeneous nuclear ribonucleoprotein L.